Volume 69, Issue 4
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645


A prospective cohort study was conducted in two villages in Zambia to compare the efficacy of praziquantel in the treatment of schistosomiasis haematobium in people with and without concomitant infection with human immunodeficiency virus (HIV). Five hundred seven individuals with infected with were enrolled and followed-up for as long as 12 months after treatment with a single dose of praziquantel. Seventy-three were coinfected with HIV. The study demonstrated that praziquantel is still very effective in the treatment and control of even when there is coinfection with HIV (without symptoms and signs of acquired immunodeficiency syndrome [AIDS]/HIV disease). Resistance to reinfection with is not altered in subjects coinfected with HIV (without symptoms and signs of AIDS/HIV disease). Individuals with coinfection excreted fewer eggs and complained less of hematuria than those without HIV infection, and the sensitivity and positive predictive value of reported hematuria as an indication of heavy infection were lower in the group coinfected with HIV. This observation may have implications for the use of hematuria as an indicator for rapid diagnosis of schistosomiasis in areas where HIV is prevalent.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. Karanja DM, Colley DG, Nahlen BL, Ouma JH, Secor WE, 1997. Studies of schistosomiasis in Western Kenya: I. Evidence for immune-facilitated excretion of schistosome eggs from patients with Schistosoma mansoni and human immunodeficiency virus coinfections. Am J Trop Med Hyg 56 : 515–521. [Google Scholar]
  2. Karanja DM, Boyer AE, Strand M, Colley DG, Nahlen BL, Ouma JH, Secor WE, 1998. Studies on schistosomiasis in western Kenya: II. Efficacy of praziquantel for treatment of schistosomiasis in persons coinfected with human immunodeficiency virus-1. Am J Trop Med Hyg 59 : 307–311. [Google Scholar]
  3. Lawn SD, Karanja DM, Mwinzia P, Andove J, Colley DG, Folks TM, Secor WE, 2000. The effect of treatment of schistosomiasis on blood plasma HIV-1 RNA concentration in coinfected individuals. AIDS 14 : 2437–2443. [Google Scholar]
  4. Mwinzi PN, Karanja DM, Colley DG, Orago AS, Secor WE, 2001. Cellular immune responses of schistosomiasis patients are altered by human immunodeficiency virus type 1 coinfection. J Infect Dis 184 : 488–496. [Google Scholar]
  5. N’Zoukoudi-N’Doundou MY, Dirat I, Akouala JJ, Penchenier L, Makuwa M, Rey JL, 1995. Bilharziasis and human immunodeficiency virus infection in Congo. Med Trop (Mars) 55 : 249–251. [Google Scholar]
  6. Sabah AA, Fletcher C, Webbe G, Doenhoff MJ, 1985. Schistosoma mansoni: reduced efficacy of chemotherapy in infected T-cell-deprived mice. Exp Parasitol 60 : 348–354. [Google Scholar]
  7. Modha J, Labertucci JR, Doenhoff MJ, McLaren DJ, 1990. Immune dependence of schistosomicidal chemotherapy: ultra-structural study of Schistosoma mansoni adult worms exposed to praziquantel and immune sera in vivo. Parasite Immunol 12 : 321–324. [Google Scholar]
  8. Doenhoff MJ, Sabah AA, Fletcher C, Webbe G, Brain J, 1987. Evidence for Immune-dependent action of praziquantel on Schistosoma mansoni in mice. Trans R Soc Trop Med Hyg 81 : 947–951. [Google Scholar]
  9. Mshinda H, Lengeler C, Hatz C, de Savigny D, 1989. Field diagnosis of urinary schistosomiasis by multiple use of nucleopore urine filters. J Parasitol 75 : 476–478. [Google Scholar]
  10. Guyatt HL, Smith T, Gryseels B, Lengeler C, Mshinda H, Siziya S, Salanave B, Mohome N, Makwala J, Ngimbi KP, Tanner M, 1994. Aggregation in schistosomiasis comparison of the relationships between prevalence and intensity in different endemic areas. Parasitology 109 : 45–55. [Google Scholar]
  11. Wilson K, Grenfell B, Shaw DJ, 1996. Analysis of aggregated parasite distributions: a comparison of methods. Funct Ecol 10 : 592–601. [Google Scholar]
  12. Fylkesnes K, Musonda RM, Kasumba K, Ndhlovu Z, Mluanda F, Kaetano L, Chipaila CC, 1997. The HIV epidemic in Zambia: socio-demographic prevalence patterns and indications of trends among childbearing women. AIDS 11 : 339–345. [Google Scholar]
  13. Doenhoff MJ, Hassounah OA, Lucas SL, 1985. Does the immunopathology induced by schistosome eggs potentiate parasite survival? Immunol Today 6 : 203–206. [Google Scholar]
  14. Cohen O, Weissman D, Fauci AS, 1999. The immunopathogenesis of HIV Infection. Paul WE, ed. Fundamental Immunology. Fourth edition. Philadelphia: Lippincott-Raven Publishers, 1455–1509.
  15. Mathew RC, Boros DL, 1986. Anti-L3T4 antibody treatment suppresses hepatic granuloma formation and abrogates antigen IL-2 production in S.mansoni infection. Infect Immunol 54 : 820–826. [Google Scholar]
  16. Boros DL, Warren KS, 1970. Delayed hypersensitivity-type granuloma formation and dermal reaction induced and elicited by a soluble factor isolated from Schistosoma mansoni eggs. J Exp Med 132 : 488–507. [Google Scholar]
  17. Colley DG, 1981. T lymphocytes that contribute to the immunoregulation of granuloma formation in chronic murine schistosomiasis. J Immunol 126 : 1465–1468. [Google Scholar]
  18. Chensue SW, Wellhausen RS, Boros DL, 1981. Modulation of granulomatous hypersensitivity. Participation of Ly 1+ and Ly 2+ T lymphocytes in the suppression of granuloma formation and lymphokine production in Schistosoma mansoni-infected mice. J Immunol 127 : 363–367. [Google Scholar]
  19. Gaines H, von Sydow MA, von Stedingk LV, Biberfeld G, Bottiger B, Hansson LO, Lundbergh P, Sonnerborg AB, Wasserman J, Strannegaard OO, 1990. Immunological changes in primary HIV-1 infection. AIDS 4 : 995–999. [Google Scholar]
  20. Masur H, Ognibene F, Yarchoan R, Shelhamer JH, Baird BF, Travis W, Suffredini AF, Deyton L, Kovacs JA, Falloon J, 1989. CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection. Ann Intern Med 111 : 223–231. [Google Scholar]
  21. Dunne DW, Hassounah O, Musallam R, Lucas S, Pepys MB, Baltz M, Doenhoff M, 1983. Mechanisms of Schistosoma mansoni egg excretion: parasitological observations in immunosuppressed mice reconstituted with immune serum. Parasite Immunol 5 : 47–60. [Google Scholar]
  22. Lengeler C, Utzinger J, Tanner M, 2002. Questionnaires for rapid screening of schistosomiasis in sub-saharan Africa. Bull World Health Organ. 80 : 235–242. [Google Scholar]
  23. Capron A, Dessaint JP, Capron M, Ouma JH, Butterworth AE, 1987. Immunity to schistosomes: progress towards vaccine. Science 238 : 1065–1072. [Google Scholar]
  24. Capron A, Dessaint JP, Capron M, Ouma JH, Butterworth AE, 1992. Immunologic aspects of schistosomiasis. Annu Rev Med 43 : 209–218. [Google Scholar]
  25. Butterworth AE, Hagan P, 1987. Immunity in human schistosomiasis. Parasitol Today 3 : 11–16. [Google Scholar]
  26. Van Lieshout L, Polderman AM, Deelder AM, 2000. Immuno-diagnosis of schistosomiasis by determination of the circulating antigens CAA and CCA, in particular in individuals with recent or light infection. Acta Trop 77 : 69–80. [Google Scholar]
  27. Masur H, Ognibene F, Yarchoan R, Shelhamer JH, Baird BF, Travis W, Suffredini AF, Deyton L, Kovacs JA, Falloon J, 1998. Evolution of Schistosoma haematobium-related pathology over 24 months after treatment with praziquantel among school children in southeastern Tanzania. Am J Trop Med Hyg 59 : 775–781. [Google Scholar]

Data & Media loading...

  • Received : 03 Jul 2002
  • Accepted : 01 Jul 2003

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error